Chu Robert Karoly, Rosic Tea, Samaan Zainab
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Case Rep Psychiatry. 2017;2017:1364894. doi: 10.1155/2017/1364894. Epub 2017 Jun 11.
Adult Attention-Deficit/Hyperactivity Disorder (ADHD) is a contentious diagnostic issue, which has been increasing in prevalence in recent years, and is often comorbid with other psychiatric disorders. This report presents a detailed account of a clinical case involving a middle-aged man with a history of recurrent depressive episodes and an unsubstantiated diagnosis of ADHD, treated with stimulants. There is persistent debate around the use of psychostimulants both in adult ADHD and in the treatment of depression. Despite promising activating properties, psychostimulants carry significant risks of misuse and substance use disorder. In this report, we consider the potential benefits and adverse effects of stimulants in the treatment of adult ADHD and mood disorders and review the learning points of this complicated, but not uncommon, clinical case.
成人注意力缺陷多动障碍（ADHD）是一个颇具争议的诊断问题，近年来其患病率不断上升，且常与其他精神障碍合并存在。本报告详细介绍了一例临床病例，患者为一名中年男子，有复发性抑郁发作史，曾被无端诊断为ADHD并接受兴奋剂治疗。关于精神兴奋剂在成人ADHD及抑郁症治疗中的应用一直存在持续的争论。尽管精神兴奋剂具有有前景的兴奋特性，但存在显著的滥用风险和物质使用障碍风险。在本报告中，我们探讨了兴奋剂在治疗成人ADHD和情绪障碍方面的潜在益处和不良反应，并回顾了这一复杂但并非罕见的临床病例的经验教训。
